The Precision Medicine Company
Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies
AlphaBiomics’ CEO Anthony Williamson invited to speak at the Bioscience Forum organised by
the BioIndustry Association (BIA) on 14th October.
Read more here.
The Precision Medicine Company
Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies
Winner of the 2018 European Innovation Quickfire Challenge (read more)